Abstract
Waterclefts and retrodots are independently associated with visual impairment, yet a review identified no data on risk factors.
Purpose
To investigate risk factors for these two human lens cataract subtypes.
Method
Two nested case–control studies: The host study comprised 1078 subjects (≥55 years) attending the Somerset and Avon Eye Study (SAES). In total, 197 watercleft cases (≥Oxford grade 0.2 in either eye) and 199 retrodot cases (≥Oxford grade 1.0 in either eye) were individually age/gender matched to controls. Detailed ophthalmic and potential risk factor data were collected, including body mass index (BMI), smoking, alcohol, diabetes, hypertension, analgesics, vitamin supplementation, nutrition, sunlight exposure, dehydration, hormonal (women), blood lipids, glucose, urea, creatinine, uric acid, and vitamin levels.
Results
For waterclefts, univariable analysis identified BMI, alcohol intake, vitamin status, sunlight, urea, creatinine, and uric acid as possible risk factors. Multivariable analysis identified two independent associations. Total number of ‘any’ analgesics in the previous year: adjusted P<0.01 (U-shaped risk profile, unadjusted high vsmedium use (=reference) OR 2.39, 95% CI 1.35–4.26 with medium use vsnone (=reference) OR 0.43, 95% CI 0.26–0.72); total sunlight: adjusted P=0.03 (unadjusted highest exposure vslowest (=reference) OR 3.25, 95% CI 1.11–9.50). For retrodots, univariable analysis identified alcohol, HRT, and lipids. Multivariable analysis identified two independent associations. Mean number of alcohol units consumed per month, adjusted P=0.02 and HDL cholesterol levels, adjusted P=0.02 (unadjusted ORs NS both).
Conclusion
This is the first available published information on risk factors for the human cataractous lens features waterclefts and retrodots.
Similar content being viewed by others
Introduction
Of the estimated 180 million people worldwide who are visually disabled, 40–45 million are blind and by definition cannot walk about unaided.1 With half the blindness due to cataract and an increasingly ageing population, the World Health Organization has estimated that the number of people currently blind due to cataract alone could double to reach over 40 million by the year 2020.1, 2 Although the backlog of blinding cataract is a major problem for the developing world,3 the problem for wealthier nations is that the provision of surgery for early cataract has become a major drain on resources.4 It has been estimated that if the onset of cataract were delayed by 10 years, the number of cataract operations needed would decrease by 45%.5 It is therefore important to identify modifiable risk factors in cataractogenesis. The prevalence of waterclefts and retrodots is fairly high, in an English population based survey of people aged 55–74 years of age waterclefts were present in 17% and retrodots in 11% of participants.6 It had been suggested that waterclefts7 and retrodots8, 9 have the potential to cause visual impairment, with symptoms including monocular diplopia,10 but until recently their effects on vision remained largely speculative. Population-based data have now shown that waterclefts are independently associated with impaired visual acuity11 and retrodots are independently associated with both impaired visual acuity and impaired contrast sensitivity. Although waterclefts and retrodots may not cause blindness, they may cause significant visual symptoms in populations with high visual requirements and high expectations of visual performance.11 With such high prevalence, strategies for prevention, as opposed to surgery, may be associated with cost-savings in countries that devote large expenditure to surgery for early cataract.
Waterclefts (Figure 1a) are fibre-based opacities that are usually situated in the anterior superficial cortical zone (52%), or both the anterior and posterior cortex (47%)12, 13 Shun-Shin et al12 suggested that changes at the membrane of the lens fibre tip could set off activation of enzymes and inhibition of the Na+K+ATP-ase pump resulting in a watercleft. Certain cortical cataracts and waterclefts might share a common aetiology, and it has been suggested that cortical cataract may be similarly caused following disruption of the Ca2+ATP-ase pump. In addition, cortical spokes and waterclefts have been noted to coexist in mixed cortical cataract,13, 14 although some of this apparent association may be due to mis-classification, as in their more advanced stages of development waterclefts can become opaque and appear similar to cortical spokes.
Bron and Brown8 defined retrodots (Figure 1b) as small (80–500 μm) round, oval or oblong birefringent features that can occur in the adult lens after the fifth decade. They are typically found in the perinuclear zones and their shape and development are independent of the lens fibre architecture.10 Two studies have found a statistically significant relationship between the presence and grade of retrodots and nuclear scatter, suggesting a possible common aetiology.14, 15
A literature review of cataract risk factors found no separate investigation into risk factors for waterclefts and retrodots. In view of the known associations between waterclefts and cortical cataract on the one hand, and retrodots and nuclear cataract on the other, findings from earlier studies on risk factors for cataract were consulted to decide which potential risk factors to investigate. The main putative risk factors considered at the time of designing the study included age (matched), gender (matched), body mass index (BMI), cardiovascular status and risks (various aspects of blood pressure, blood lipids), systemic comorbidities (treated hypertension, history of diabetes, blood glucose, gout—uric acid), smoking, alcohol intake, sunlight exposure (UV), nutrition (daily energy intake, vitamins A, C, and E, various supplements, blood levels for carotenoids and vitamins A and E), medications (various analgesics, antihypertensives) hormonal status (women), dehydration, and renal function (see West for review of information available at the time of study design16).
Purpose
The aim of this study was to investigate the associations between suspected risk factors for cataract and the presence of waterclefts or retrodots in the human crystalline lens.
Two primary hypotheses were tested:
-
1
That some or all of the risk factors listed above are risk factors for the presence of waterclefts.
-
2
That some or all of the risk factors listed above are risk factors for the presence of retrodots.
Method
The study design consisted of two nested case–control studies, where the host study was the Somerset and Avon Eye Study (SAES).17, 18 The host study included 1078 subjects who attended the SAES research clinic, held at Bristol Eye Hospital and who provided a full data set. Somerset and Avon Eye Study was designed to investigate the population requirements for cataract surgery.17 The source of potential subjects for the SAES was the Somerset and Avon Survey of Health (SASH), an age/gender stratified random sample of subjects aged at least 55 years registered at 40 general practices in Avon and Somerset.19 The study was approved by the United Bristol Healthcare Trust Local Ethics Committee.
Abbreviated SAES clinic protocol
Once written consent had been obtained, subjects participated in the various clinic tests, in the order listed in Table 1.
Lens grading: the Oxford Clinical Cataract Classification and Grading System (OCCCGS)
The Decimalized Oxford Clinical Cataract Classification and Grading System20, 21 is designed for grading at the slit lamp and includes anterior subcapsular (ASC), posterior subcapsular (PSC), cortical spokes, fibre folds, vacuoles, focal dots, nuclear brunescence, white nuclear scatter, waterclefts, and retrodots (Figure 1). All features are scored from 0 to 5 on a decimalized scale. There is a linear relationship between most scales with logarithmic conversions for certain features where this is more appropriate, that is, vacuoles, retrodots, and focal dots.
Case–control selection
Within the SAES, two nested case–control studies were constructed to investigate the two primary hypotheses (Figure 2). Cases for the two studies were respectively defined as those subjects with at least grade 0.2 waterclefts in either eye or at least grade 1.0 retrodots in either eye.21 It was decided that these were the levels at which each feature could be said with confidence to be present. Case selection was irrespective of the presence of any other lens feature. Pupil diameters for all cases had to be at least 6.0 mm in the eye with the feature to minimize misclassification. No visual acuity criterion was used to determine case or control selection. The criteria for the controls for the two studies were absent or less than grade 0.2 waterclefts in both eyes, or absent or less than grade 1.0 retrodots in both eyes21 with a pupil diameter of at least 6.0 mm in both eyes. The presence of any other cataract feature was not taken into account. Matched controls were selected for each case using a program written especially for this project using the programming language within Microsoft Access where the study database had been constructed. The program individually matched a control to each case, first by gender and then by age on the day of their clinic visit, to the nearest day.
Risk factor information
The information gathered in the Host SAES17 was supplemented with additional data. Three additional questionnaires were used to collect further information on the case–control study subjects. These covered possible risk factors including smoking, alcohol intake, nutrition (food frequency), sunlight exposure, dehydration, and hormonal history (women). The sunlight questionnaire was telephone administered by interviewers who were masked to the case–control status of the subjects, the other supplementary questionnaires were postal. A variety of analyses were performed on stored blood samples. A summary of data items and variable types is provided in Table 2.
Statistical analysis
All data were entered into an Access database, checked for errors, and transferred to the SPSS software package. All univariable and multivariable analyses were carried out using SPSS.
Statistical power
Post hoc power calculations were performed for all the variables of interest. For the vast majority of variables, the sample sizes and distributions were such that the standardized detectable effect size was 0.3 or 0.4 of an SD (small to medium effect) for at least 80% power at the 5% probability level for both waterclefts and retrodots. Where subgroup analyses examined only one gender (eg reproductive history for women), power was attenuated to detection of an effect size of 0.4 or 0.5 of an SD (medium effect).
Univariable analysis
Although the cases and controls had been individually matched for age and gender, the univariable analysis was carried out as if the cases and controls were unpaired. This was because for a number of the variables, subjects had missing data, which would have resulted in some case–control pairs being excluded. Other than being matched for age and gender, the samples were independent, hence the independent samples t-test, corrected for ties, was used for continuous data to test for differences between the cases and controls. Where numbers were too small or the data were too skewed, the Mann–Whitney Rank Sum W test, corrected for ties, was used instead. Paired analyses were performed ad hoc for certain variables. Continuous variables were also divided into four categories. Where there were ‘a priori’ reasons for choice of cut points (eg compatibility with previous studies) then these were used, otherwise data were divided into quartiles, or where a natural zero ‘first category’ existed the nonzero values were divided into tertiles (Table 2). χ2 tests were carried out on the categorical data and the Mantel–Haenszel test for linear association was used on categorical data where appropriate to test for trends. For initial hypothesis generation, the 10% level of significance was accepted; where a higher significance was found, this was noted. This relatively liberal level was chosen so as not to miss any significant results, which would be masked by negative confounding. Despite the use of a 10% threshold in the initial univariable analysis, the presentation of results reverts to standard format with probability values stated for continuous data and odds ratios with 95% confidence intervals given for categorical analyses. For the multivariable analysis, the more stringent 5% level of significance was used for inclusion/exclusion throughout.
Multivariable analysis
Variables significant at the 10% threshold from the univariable analysis were entered into a multivariable logistic regression model using backwards selection. Age and gender were forced into the model and for all other variables probability levels for entry or removal from the model were 0.05. Where appropriate, significant variables within the same group, for example ‘sunlight’, were initially put into separate multivariable models to see which variable(s) from this group remained significant for inclusion in the final multivariable model.
Results: waterclefts
Prevalence of OCCCGS features in watercleft cases and controls
The study involved 197 watercleft cases and 197 age- and gender-matched controls. For cases, the mean OCCCGS watercleft score was 0.42 (SD 0.57) in the right eye, 0.47 (SD 0.46) in the left eye and 0.58 (SD 0.55) in the worse eye. The range of scores in the worse eye was from 0.2 to 4.0.
Univariable analysis: waterclefts
Separate univariable ‘hypothesis generating’ analysis at the 10% significance level suggested that the following variables might be important risk factors for waterclefts: BMI; alcohol consumption (highest ever level); analgesic use; mean annual sunlight exposure; mean plasma creatinine, urea; uric acid; vitamin A and vitamin E blood levels (see Table 3).
Body mass index
There was no significant difference in mean BMI between cases and controls. Univariable analysis however suggested a U-shaped risk profile with differences between four BMI categories. There was an increased risk for subjects with a BMI of more than 30 compared to those with a BMI of 26–29 (as reference category): OR 1.78 (95% CI 1.05–3.10). The odds ratios also suggested a protective effect for those with a BMI of 26–29 relative to those in the lowest category of less than 22 (as reference category): OR 0.52 (95% CI 0.32–0.86).
Alcohol consumption
In this study, ‘highest ever’ alcohol consumption showed a statistically reduced risk of having waterclefts for all three categories compared to ‘never drinks alcohol’. This reduced risk was similar for all three categories of alcohol frequency, from OR 0.53 (95% CI 0.28–0.98) for ‘heavy’ vs ‘never’ to OR 0.47 (95% CI 0.25–0.91) for ‘moderate’ vs ‘never’ and 0.49 (95% CI 0.30–0.81) for ‘light’ vs ‘never’. The Mantel–Haenszel test for linear association showed a significant trend between the four categories of alcohol consumption (P=0.02). There was no association between the most recent 1 month's alcohol intake, that is, current intake and waterclefts or the mean monthly alcohol consumption over the past 1 year and waterclefts.
Analgesics
In total, 106 Watercleft cases and 125 controls reported use of paracetamol or a paracetamol containing products, aspirin, or ibuprofen in the past month. Cases were found to have taken a significantly greater number of paracetamol or paracetamol containing products in the past 12 months (P=0.04).
‘Any’ analgesics referred to the total number of paracetamol, paracetamol containing products, aspirin, or ibuprofen. The cases had taken a highly significant greater total number of ‘any’ analgesics than the controls (P=0.003). The odds ratios showed an increased risk for the highest use group (greater than 253 analgesics in the past year) compared to medium use (as reference, 8–252 analgesics in the past year) OR 2.39 (95% CI 1.35–4.26). Comparing the highest use group with both infrequent use (1–7 in past year) and no analgesic use, the results were in the same direction but the 95% CI for the odds ratios all overlapped 1.0, that is nonsignificant. The results suggested a U or J-shaped risk profile with a protective effect of medium and low total dose of ‘any’ analgesics compared to no analgesics at all. The odds ratio for the medium use group compared to using none (as reference category) was OR 0.43 (95% CI 0.26–0.72). The category with the lowest risk was the medium use group, and although further comparisons were in keeping with a U or J-shaped risk profile these did not yield significant differences, with 95% confidence intervals overlapping 1.0.
Sunlight
Watercleft cases appeared to have significantly higher mean annual sunlight exposure than controls (P=0.07). The observed difference between the mean number of sun years for the cases and controls was 0.18 sun years. A three-fold increased risk was found for watercleft subjects in the highest exposure category compared to the lowest OR 3.25 (95% CI 1.11–9.50). The Mantel–Haenszel test for linear association showed a significant trend between the 4 sun year categories (P=0.06).
Urea levels
Mean levels of plasma urea were within the ‘normal’ range for both cases and controls. The independent samples two-tailed t-test showed a significant difference between the mean level of urea with watercleft cases having higher levels (P=0.001). Univariable results showed a significantly increased risk both for subjects in the highest quartile compared to those in the lowest OR 2.44 (95% CI 1.31–4.56) and also for subjects in the highest quartile compared to the second lowest OR 2.62 (95% CI 1.37–4.99). The Mantel–Haenszel test for linear association showed a significant trend across the quartiles (P=0.003).
Creatinine
The independent samples two-tailed t-test showed a significant difference between the mean level of creatinine for the two groups, with cases having higher creatinine levels (P=0.02). As ‘normal’ creatinine levels differ for males and females, a paired analysis was also performed and the unpaired analysis was repeated by gender. The paired analysis indicated a significantly higher mean creatinine level among cases (P<0.01) with the Wilcoxon matched pairs ranked signs test showing a highly significant trend between the quartiles (P<0.001). For female (but not male) subjects, there was a significant difference (unpaired) in mean creatinine with female cases having higher levels (P=0.01). There was a significantly increased risk for female subjects in the highest quartile compared to the lowest OR 3.69 (95% CI 1.47–9.27), and also for the highest compared to the second lowest quartile OR 3.28 (95% CI 1.25–8.59). The Mantel–Haenszel test for linear association showed a highly significant trend between the quartiles (P=0.007). The amounts of creatinine (and urea) excreted are closely related to the glomerular filtration rate (GFR). The independent samples two tailed t-test showed that the difference between the GFR for female cases and controls was not significant (P=0.15). The risk associated with increased urea levels noted above in females was therefore not due to poor glomerular filtration.
Uric acid
The normal plasma uric acid level is approximately 240 μmol/l. In the SAES both watercleft cases and controls had higher mean levels of uric acid (347.48 and 327.26 μmol/l, respectively). Separate analysis, by gender, revealed that only for females was there a highly significant difference between the mean level of uric acid for the two groups, with cases having higher levels of uric acid than controls (P=0.01). Categorical analysis revealed a significantly increased risk for female subjects in the highest quartile compared to the lowest OR 2.57 (95% CI 1.14–5.77) and also for those in the highest quartile compared to the second lowest OR 2.94 (95% CI 1.35–6.40). The Mantel–Haenszel test for linear association showed a significant trend between the quartiles for female subjects (P=0.03).
Vitamin A levels
The daily beta-carotene dietary intake of the cases and controls (1998 and 2128 μg, respectively) did not differ significantly (P=0.75). These equate to retinol equivalents of 333 and 355 μg. As the estimated average daily requirements for this age group are 500 μg retinol/day for males and 400 μg/day for females, this suggests that both cases and controls had a low vitamin A intake. There was a significant difference in the mean vitamin A levels of the cases and controls, as measured on the blood samples, with cases having higher levels than controls (P=0.02). The Mantel–Haenszel test for linear association showed a significant trend between the four quartiles of vitamin A blood levels (P=0.04). No significant risk was observed for subjects in the highest compared to those in the lowest quartile OR 1.70 (95% CI 0.91–3.16). No significant difference was observed between the total carotenoid levels of the blood samples of the cases and controls (P=0.30).
Vitamin E levels
The mean daily vitamin E intake of the cases (7.81 mg) and controls (8.47 mg) did not differ significantly (P=0.24). The approximate vitamin E requirement for men is 7 mg/day, and for women 5 mg/day,22 so both cases and controls appeared to consume adequate dietary vitamin E. For blood levels, our results showed a significant risk for subjects in the highest compared to those in the lowest quartile of plasma vitamin E levels OR 1.91 (95% CI 1.02–3.57). The Mantel–Haenszel test for linear association also showed a significant trend between the four quartiles of vitamin E blood levels (P=0.07).
Multivariable analysis: waterclefts
When all the significant variables from the univariable analysis were entered into the final multivariable model, two variables remained significant at the 5% level. The total number of ‘any’ analgesics used in the past year was highly significantly associated with waterclefts, with increased analgesic use being associated with a higher risk of waterclefts (P<0.01). Total lifetime sunlight exposure was also significantly associated with waterclefts, with higher light exposure associated with a higher risk of having waterclefts (P=0.03).
Results: retrodots
Prevalence of OCCCGS features in retrodot cases and controls
The study involved 199 retrodot cases and 199 age- and gender-matched controls.
For cases the mean OCCCGS retrodot grade was 1.59 (SD 0.89) in the right eye, 1.66 (SD 0.88) in the left eye, and 1.96 (SD 0.72) in the worse eye. The range of scores in the worse eye was from 1.0 to 4.0.
Univariable analysis: retrodots
Separate univariable ‘hypothesis generating’ analyses at the 10% significance level suggested that the following variables might be important risk factors for retrodots: alcohol consumption (mean number of alcohol units consumed per month); hormone replacement therapy (HRT); mean high density lipoprotein (HDL) cholesterol levels; mean triglyceride levels (see Table 4).
Alcohol consumption
Univariable results indicated a significant difference between the mean monthly alcohol intake over the past year of cases and controls (P=0.03), with controls drinking a greater total number of alcohol units (30.9 U/month) than cases (20.6 U/month). However, although the odds ratios for ‘heavy’ alcohol consumption (as reference category) compared to ‘never’, ‘light’, and ‘moderate’ consumption were in a protective direction (eg OR 0.49 for ‘heavy’ vs ‘never’), the 95% confidence intervals overlapped 1.0 in all cases (ie results not statistically significant at P<0.5). There was no association between the most recent 1 month's alcohol intake, that is, current intake and retrodots or the ‘highest ever’ category of alcohol consumption and retrodots.
Hormonal history
Only 14 cases and seven controls had reported HRT use. A borderline effect was observed for retrodot cases using HRT for more years than controls (Mann–Whitney rank sum W test P=0.05). There was no significant difference between the mean number of years of contraceptive pill use for retrodot cases and controls. Neither was there any increased risk of retrodots associated with the number of completed pregnancies or the mean number of years of menstruation.
Cholesterol levels
A borderline significant difference was observed between the levels of HDL cholesterol (P=0.10) with cases having higher levels of HDL cholesterol than controls. When odds ratios were calculated for the various quartiles of HDL values, no significantly increased risk was associated with any one category relative to any other. Also, a higher HDL : cholesterol ratio was found in cases than controls (P=0.08).
Triglyceride levels
A borderline difference between the mean level of triglycerides for the two groups (P=0.10) was found with cases having lower triglyceride levels than controls (1.99 and 2.17 mmol/l, respectively).
Multivariable analysis: retrodots
Multivariable analysis confirmed two of the variables as independent risk factors for retrodots: the mean number of alcohol units consumed per month over the past year, with higher alcohol consumption providing a protective effect (P=0.02) and HDL cholesterol levels, with higher HDL associated with an increased risk of retrodots (P=0.02).
Discussion
Case–control studies are well placed to identify risk factors for a condition of interest. Individual matching for age and gender followed by adjustment for these and other potential confounders strengthen the credibility of this observational methodology. Since we matched for age and gender, our study design does not permit any comment on the possible importance of either of these two variables as risk factors. A general expectation however would be that increasing age would be an important risk for both waterclefts and retrodots, hence the need for case–control matching. Our staged approach of univariable hypothesis generation at a liberal significance level (10%) followed by more stringent multivariable analyses has yielded a number of items for discussion. Quantification of exposures by more than one method has provided complimentary views for several factors of interest. For example, vitamin status was assessed in terms of nutritional intake based on food frequency questionnaires, supplement use, and vitamin levels from biochemical analysis of stored blood samples, and alcohol consumption was assessed in terms of the current intake over the previous 1 month, the average monthly intake over the past year, and the highest ever intake, to acknowledge that some individuals may have experienced important variations in intake at different times during their lives (see Table 2). While this staged and complimentary approach has certain advantages, it must be cautioned that multiple testing at the 10% level would have produced a number of chance associations in the initial results. Several factors however remained significant in the multivariable analyses conducted at the 5% level. The power of the study was sufficient to state with reasonable confidence that within the population studied a number of the hypothesized risk factors examined did not contribute medium to large effects, although small effects may have gone undetected.
Risk factors for waterclefts identified by univariable analysis included BMI, alcohol intake, vitamin status, sunlight exposure, indices of renal function, and uric acid levels (see Table 3). A U-shaped relationship was noted for BMI suggesting a lower risk for individuals with intermediate BMI. The obese subjects with a BMI of greater than 30 had a greater risk (OR=1.78) compared to those with an intermediate BMI of between 26 and 29. Those with intermediate BMI had almost half the risk (OR=0.52) of those subjects with a lower BMI of less than 22. Our finding is comparable with that of the Blue Mountains Eye Study23 for cortical and PSC cataract, the Boston Nurses’ Health Study cohort24 for posterior subcapsular opacities, the Salisbury Eye Evaluation (SEE) project25 for cortical opacity only with opposite effect for nuclear opacity, and the Framingham Eye Study cohort26 for incident cortical and posterior subcapsular opacities.
For the variable ‘highest ever alcohol consumption’, we found that all levels of alcohol consumption had a protective effect for waterclefts. The risk was roughly halved for those who consumed alcohol at all three intake levels (OR=0.53; 0.47; 0.49 highest to lowest), compared to those subjects who did not drink any alcohol. Similar protection was observed in the Boston Nurses’ Health Study27 for light to moderate wine consumption for cortical opacity. The Beaver Dam Eye Study,28 however, found no associations between alcohol and any form of incident cataract over a 10 year period. Earlier studies have found a protective effect for certain patterns of (light) alcohol consumption for cataract although mostly these studies have reported heavy alcohol consumption to be a risk, particularly for nuclear cataract.16, 29, 30, 31, 32, 33 In a number of these previous studies, heavy alcohol consumption has been defined as over four alcoholic drinks per day. In the case–control populations, we studied there were under 10% of participants who reported ‘heavy’ drinking, which we defined as greater than 80 alcohol units per month (approximately >2½U/day). This rate of alcohol consumption is lower than that reported for England as a whole (household survey data) where around 27% of men and 15% of women reported using this quantity of alcohol.34
A strongly significant excess in total number of ‘any’ analgesics was observed among cases, with a similar but statistically weaker effect seen for paracetamol (containing) products. For ‘any’ analgesics the risk between medium users (who took 8–252 analgesics a year as reference category) and those who took more (high use) was more than double (OR=2.39). A U-shaped risk profile was observed with medium analgesic users showing a protective effect (risk halved, OR=0.43) compared with those who took no analgesics at all. These findings suggest that complete avoidance of analgesics is associated with some increased watercleft risk, but the dominant effect appears to be an increased risk with high levels of use of these medications. The published literature is divided as to whether analgesic use, particularly aspirin, is a risk for cataract, protective or neither.35, 36, 37, 38 Interpretation of observational data related to drug use is fraught with difficulties. Conflicting results in different studies may be due to a range of confounders and biases. Different doses may produce different effects and reasons for the taking of ‘over the counter medications’ will vary widely, with the possibility that an underlying condition prompting the use of a drug may itself be associated with an increased risk of cataract.
Numerous published studies on sunlight and cataract provide evidence in support of an association between ultraviolet radiation (UVR) and cortical cataract (see McCarty and Taylor39 for a review). In the present study, mean sunlight exposure was higher among watercleft cases than controls, with over a three-fold greater risk (OR=3.25) in the highest exposure quartile compared with the lowest, and a significant trend across quartiles. The level of risk was similar to that found in the Maryland watermen study for cortical cataract.40 These results suggest that even for subjects who had predominantly lived in the UK, there was a sufficient range of sunlight exposures to detect a possible three-fold excess risk of waterclefts in subjects with the greatest mean annual level of exposure.
The indices of renal function, urea, and creatinine levels, both indicated a higher risk of waterclefts associated with relatively worse renal function. There was a two and a half fold increase in risk for those in the highest urea quartile compared with both the lowest (OR=2.44) and second lowest (OR=2.62) quartiles. Creatinine levels among female (only) subjects indicated a similar pattern with a three and a half fold increase in risk for the highest quartile compared with the lowest (OR=3.69) and second lowest (OR=3.28) quartiles, and a strongly positive linear trend. The GFR did not reflect these patterns indicating that the variations in urea and creatinine levels were not due to poor glomerular filtration. The Beaver Dam Eye Study found blood urea nitrogen to be raised in association with cortical cataract over a 5 year period in univariable analysis, an association which disappeared after controlling for age.41 A large case–control study of 1000 cases and 1000 individually matched controls in the UK found urea to be associated with PSC but not with cortical cataract.42
Uric acid plasma level appeared slightly elevated for both cases and controls. Female watercleft cases had a higher mean uric acid with a two and a half to three fold excess risk for those in the highest quartile compared with those in both the lowest (OR=2.57) and second lowest (OR=2.94) quartiles. A significant linear trend across categories was noted. This result accords with published associations between gout and cortical cataract,43 gout medications and mixed cataract,44 and higher uric acid and both mixed opacities45 and PSC cataract.46
Previous studies have reported a variety of associations between risk of cataract or cataract extraction and antioxidant vitamin status (dietary intake, supplementation, or blood levels). In the present study, dietary beta-carotene intake was lower than expected for both cases and controls, with no group differences observed. Mean vitamin A blood levels were higher among cases than controls, with a significant linear association for trend across the quartiles, suggesting an increased risk of waterclefts with higher blood levels. No differences were observed however for total carotenoid levels. The Nutritional Factors in Eye Disease Study found use of multivitamin preparations to be associated with an increased risk of cortical opacities but a decreased risk of nuclear sclerosis.47 In the Blue Mountains Eye Study, vitamin A supplements were protective against nuclear (but not cortical) cataract with folate and vitamin B12 supplements protective against cortical cataract48 and vitamin A dietary intake protective for nuclear cataract.49
Mean dietary intake of vitamin E was adequate and similar among cases and controls. Univariable analysis of plasma vitamin E levels suggested an increase of almost twice the risk of waterclefts between lowest and highest quartiles (OR=1.91). The observed effect was strengthened by a significant trend across quartiles supporting the notion of a dose response. A placebo-controlled double-masked randomized trial of vitamin E supplementation found no effect on incidence or progression of cortical, nuclear, or PSC cataract from 500 IU daily over 4 years.50 A multicentered, prospective, double-masked, randomized, placebo-controlled, 3-year trial of a mixture of oral antioxidant micronutrients (mg/day) (beta-carotene (18), vitamin C (750), and vitamin E (600)) in 297 subjects was found to have a small but significant beneficial effect on cataract progression as measured by digital image analysis of retro-illumination lens images.51 In the Beaver Dam Eye Study, the use of multivitamins or any supplement containing vitamin C or E for more than 10 years duration lowered the risk for nuclear and cortical cataracts.52 In the Boston Nurses’ Health Study, after adjustment for other nutrients vitamin C intake remained significantly protective against nuclear opacification as did duration of vitamin C supplement use and plasma measures of vitamins C and E.53 In the Lens Opacities Case–control Study, the risk of nuclear opacities was reduced to less than one half in participants with higher levels of vitamin E.45 In a Mediterranean case–control study of mixed cataract dietary intake of vitamins C, E and selenium were marginally associated with decreased risk, and blood levels of vitamin C above 49 μmol/l were associated with a 64% reduction of the odds for cataract.54 In the present case–control studies we did not find associations with dietary vitamin C. In a study in the north of England the risk of nuclear cataract, after adjustment, was lowest in people with the highest plasma concentrations of alpha-carotene or beta-carotene; cortical cataract risk was lowest in people with the highest plasma concentrations of lycopene and PSC cataract risk was lowest in those with higher concentrations of lutein.55
In the present study, multivariable logistic regression incorporating all significant univariable results confirmed at a 5% probability level that the number of ‘any’ analgesics used in the past year and the total lifetime sunlight exposure were significant independent risk factors for waterclefts, with higher exposures to each conferring greater risk. While this concurs with an accepted risk of sunlight exposure for cortical cataract,39 previous studies have been divided on the question of risk from analgesic use.35, 36, 37, 38
Retrodot risk factors identified at the 10% significance level by univariable analysis included alcohol consumption, HRT, HDL cholesterol levels, and triglyceride levels (see Table 4). Controls consumed on average 50% more alcohol in an average month over the previous year than retrodot cases, with ‘heavy’ drinkers (over 2.5 units of alcohol per day) having around half the risk (OR=0.49) of nondrinkers. The other self-reported estimates of alcohol consumption (past month or current and highest ever) were not found to be significant. These results are similar to those found for waterclefts in this study and as noted above accord with certain previous studies, which have found a protective effect of light alcohol consumption for cataract. In the Boston Nurses’ Health Study cohort, wine drinking was found to be protective against cortical cataract, but conversely these authors reported that nuclear opacity increased by 30% per 10 g increase of total alcohol intake.27 Although the Beaver Dam Eye Study found no associations between alcohol and any form of incident cataract at the 10 year review,28 this study had previously reported a borderline effect of increased risk of incident nuclear cataract associated with increasing alcohol intake at the 5-year follow-up assessment.56 Earlier studies have found a protective effect for certain patterns of (light) alcohol consumption for cataract although mostly these studies have reported heavy alcohol consumption to be a risk, particularly for nuclear cataract.16, 29, 30, 31, 32, 33 As noted above, our study population consisted mostly of relatively light drinkers, which could explain the absence of any observed harmful effects of ‘heavy’ alcohol use in our participants.
Among women using HRT retrodot cases reported significantly more years of HRT use than controls. This observation should be interpreted with caution due to the small numbers involved. None of the other elements of hormonal history were different between the groups. In the Blue Mountains Eye Study those who had ever used HRT had a decreased incidence of cortical cataract affecting any eye compared with those who had never used HRT. Older age at menarche was associated with an increased incidence of cataract surgery and of nuclear cataract. There was also a decreasing incidence of cataract surgery with increasing duration of reproductive years.57 At the baseline examination, the Beaver Dam Eye Study found that current use of postmenopausal estrogens was associated with a decreased risk of more severe nuclear sclerosis and younger age at menarche was also associated with a protective effect regarding nuclear sclerosis. Older age at menopause was associated with a decreased risk of cortical opacities.58 The 5 year review, however, did not confirm these observations, the only finding being a borderline trend suggesting a possible protective effect of increasing number of live births on incident PSC cataract.59 The SEE study found that HRT was not associated with incident nuclear, cortical, or PSC opacities, or with progression of nuclear or cortical opacification. Women who had an early menopause had a higher risk of nuclear progression, whereas those who had a later menopause had a lower risk.60 Among the Boston area participants of the Nurses Health Study, the only aspect of hormonal history or HRT use associated with cataract was current use of oestrogen only preparations with a halving of the risk of nuclear opacities compared to women who had never used HRT.61
In terms of cardiovascular risk factors in this study, HDL cholesterol and the HDL : cholesterol ratio was higher among retrodot cases. Cases were also found to have lower triglyceride levels of borderline significance. In the Blue Mountains Eye Study, cortical cataract was associated at baseline with a history of myocardial infarction, higher plasma fibrinogen, and higher serum cholesterol. Nuclear cataract was associated with a higher platelet count but hypertension was associated with lower prevalence of nuclear cataract. Posterior subcapsular cataract was associated with higher plasma fibrinogen and lower BMI.62 At baseline in the Beaver Dam Eye Study, for cortical cataract, higher serum HDL cholesterol was associated with decreased risk in women. For PSC cataract, men with higher ratios of total to HDL cholesterol were at increased risk. Associations were not found for nuclear cataract.63 In a UK case–control study of 1000 cases and 1000 controls reduced levels of total cholesterol were associated with all forms of cataract.42 In a South African clinic based population, a strong association was found between HDL cholesterol levels and lens opacities. Below an HDL-C level of 1.5 mmol/l subjects had a seven-fold higher calculated probability of falling in the lens opacity subgroup than those above this level. An association was also found between high (>5) LDL : HDL ratios and lens opacities.64 There appears to be little consistency among these results from different studies.
Multivariable logistic regression confirmed that the mean number of units of alcohol consumed in a month and HDL cholesterol were each independently associated with retrodots at the 5% significance level. Higher mean alcohol intake was protective against retrodots. This relationship has been observed in previous studies for cortical cataract but not for nuclear opacification. The present finding of increased risk associated with higher HDL cholesterol is less in keeping with published results for other cataract morphologies.
Several previously identified risk factors for cataract were notable for their absence among the positive associations found in these case–control studies of waterclefts and retrodots. No associations with age and gender were expected because cases and controls were matched for these variables. The authors were however surprised that certain other documented risks, cigarette smoking16, 28, 65 and blood glucose or diabetes35, 65, 66 for example, did not feature among our identified risk factors. For most variables the power of the studies was sufficient to exclude, with some confidence, medium to large effects for the negative findings in our two study populations. Certain negative findings however might have occurred as a result of small numbers of participants being involved, for instance there were under 5% of subjects with diabetes in each of the case–control study samples.
The SAES is the first to report details on risk factors for the visually significant cataract features waterclefts and retrodots separately. The case–control methodology and sample size provide reasonable power for investigation of these factors. In addition to the identified associations, our two case–control studies were able to rule out medium to large effects in this population for certain of the hypothesised risk factors such as cigarette smoking. Although causal associations cannot be deduced or assumed on the basis of this methodology, this work suggests a need for investigation of the factors identified here in other populations.
References
WHO. Magnitude and causes of visual impairment, World Health Organisation Fact Sheet No. 282 2004. http://www.who.int/mediacentre/factsheets/fs282/en/.
Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya'ale D, Negrel AD et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol 2004; 11: 67–115.
Brian G, Taylor H . Cataract blindness—challenges for the 21st century. Bull World Health Organ 2001; 79: 249–256.
Sparrow JM, Frost NA . How should cataracts be measured? Eye 2004; 18: 763–764.
Thylefors B . The World Health Organization's programme for the prevention of blindness. Int Ophthalmol 1990; 14: 211–219.
Deane JS, Hall AB, Thompson JR, Rosenthal AR . Prevalence of lenticular abnormalities in a population-based study: Oxford Clinical Cataract Grading in the Melton Eye Study. Ophthalmic Epidemiol 1997; 4: 195–206.
Brown NA . The morphology of cataract and visual performance. Eye 1993; 7 (Part 1): 63–67.
Bron AJ, Brown NA . Perinuclear lens retrodots: a role for ascorbate in cataractogenesis. Br J Ophthalmol 1987; 71: 86–95.
Hemenger RP . Light scatter in cataractous lenses. Ophthalmic Physiol Opt 1990; 10: 394–396.
Brown N, Shun-Shin G . Morphological correlations of clinical lens changes: non-opaque lens defects. Prog Retin Eye Res 1995; 14: 453–472.
Frost NA, Sparrow JM, Moore L . Associations of human crystalline lens retrodots and waterclefts with visual impairment: an observational study. Invest Ophthalmol Vis Sci 2002; 43: 2105–2109.
Shun-Shin G, Vrensen G, Brown N, Willekens B, Bron A, McDonald B . Does the pathogenesis of waterclefts reside in the lens membrane. Eurage Top Ageing Res Europe 1991; 15: 261–271.
Brown NP, Harris ML, Shun-Shin GA, Vrensen GF, Willekens B, Bron AJ . Is cortical spoke cataract due to lens fibre breaks? The relationship between fibre folds, fibre breaks, waterclefts and spoke cataract. Eye 1993; 7 (Part 5): 672–679.
Thompson JR, Deane JS, Hall AB, Rosenthal AR . Associations between lens features assessed in the Oxford Clinical Cataract Classification and Grading System. Ophthalmic Epidemiol 1997; 4: 207–212.
Shun-Shin GA, Bron AJ, Brown NP, Sparrow JM . The relationship between central nuclear scatter and perinuclear retrodots in the human crystalline lens. Eye 1992; 6 (Part 4): 407–410.
West SK, Valmadrid CT . Epidemiology of risk factors for age-related cataract. Surv Ophthalmol 1995; 39: 323–334.
Frost A, Hopper C, Frankel S, Peters TJ, Durant J, Sparrow J . The population requirement for cataract extraction: a cross-sectional study. Eye 2001; 15: 745–752.
Frost A, Eachus J, Sparrow J, Peters TJ, Hopper C, Davey-Smith G et al. Vision-related quality of life impairment in an elderly UK population: associations with age, sex, social class and material deprivation. Eye 2001; 15: 739–744.
Eachus J, Williams M, Chan P, Davey-Smith G, Grainge M, Donovan J et al. Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ 1996; 312: 287–292.
Sparrow JM, Bron AJ, Brown NA, Ayliffe W, Hill AR . The Oxford Clinical Cataract Classification and Grading System. Int Ophthalmol 1986; 9: 207–225.
Sparrow NA, Frost NA, Pantelides EP, Laidlaw DA . Decimalization of The Oxford Clinical Cataract Classification and Grading System. Ophthalmic Epidemiol 2000; 7: 49–60.
Department of Health. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. HMSO: London, 1991.
Younan C, Mitchell P, Cumming R, Rochtchina E, Panchapakesan J, Tumuluri K . Cardiovascular disease, vascular risk factors and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2003; 10: 227–240.
Jacques PF, Moeller SM, Hankinson SE, Chylack Jr LT, Rogers G, Tung W et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr 2003; 78: 400–405.
Caulfield LE, West SK, Barron Y, Cid-Ruzafa J . Anthropometric status and cataract: the Salisbury Eye Evaluation project. Am J Clin Nutr 1999; 69: 237–242.
Hiller R, Podgor MJ, Sperduto RD, Nowroozi L, Wilson PW, D'Agostino RB et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 1998; 105: 1244–1250.
Morris MS, Jacques PF, Hankinson SE, Chylack Jr LT, Willett WC, Taylor A . Moderate alcoholic beverage intake and early nuclear and cortical lens opacities. Ophthalmic Epidemiol 2004; 11: 53–65.
Klein BE, Klein R, Lee KE, Meuer SM . Socioeconomic and lifestyle factors and the 10-year incidence of age-related cataracts. Am J Ophthalmol 2003; 136: 506–512.
Harding JJ . Recent studies of risk factors and protective factors for cataract. Curr Opin Ophthalmol 1997; 8: 46–49.
Phillips CI, Clayton RM, Cuthbert J, Qian W, Donnelly CA, Prescott RJ . Human cataract risk factors: significance of abstention from, and high consumption of, ethanol (U-curve) and non-significance of smoking. Ophthalmic Res 1996; 28: 237–247.
Ritter LL, Klein BE, Klein R, Mares-Perlman JA . Alcohol use and lens opacities in the Beaver Dam Eye Study. Arch Ophthalmol 1993; 111: 113–117.
Munoz B, Tajchman U, Bochow T, West S . Alcohol use and risk of posterior subcapsular opacities. Arch Ophthalmol 1993; 111: 110–112.
Harding JJ, van Heyningen R . Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br J Ophthalmol 1988; 72: 809–814.
Department of Health. Statistics on alcohol: England. 2004; 5: 1–62 (ISBN 1 84182 886 6, http://www.doctors.net.uk/login/Frameset.aspx?20040929094500).
Hennis A, Wu SY, Nemesure B, Leske MC . Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol 2004; 122: 525–530.
Klein BE, Klein R, Lee KE, Danforth LG . Drug use and five-year incidence of age-related cataracts: The Beaver Dam Eye Study. Ophthalmology 2001; 108: 1670–1674.
Christen WG, Ajani UA, Schaumberg DA, Glynn RJ, Manson JE, Hennekens CH . Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I. Arch Ophthalmol 2001; 119: 405–412.
Cumming RG, Mitchell P . Medications and cataract. The Blue Mountains Eye Study. Ophthalmology 1998; 105: 1751–1758.
McCarty CA, Taylor HR . A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol 2002; 35: 21–31.
Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Abbey H et al. Effect of ultraviolet radiation on cataract formation. N Engl J Med 1988; 319: 1429–1433.
Klein BE, Klein R, Lee KE . Renal function abnormalities and incident cataract after a five-year interval: The Beaver Dam Eye Study. Curr Eye Res 1998; 17: 720–725.
Donnelly CA, Seth J, Clayton RM, Phillips CI, Cuthbert J . Some plasma constituents correlate with human cataract location and nuclear colour. Ophthalmic Res 1997; 29: 207–217.
McCarty CA, Mukesh BN, Fu CL, Taylor HR . The epidemiology of cataract in Australia. Am J Ophthalmol 1999; 128: 446–465.
Leske MC, Chylack Jr LT, Wu SY . The lens opacities case–control study. Risk factors for cataract. Arch Ophthalmol 1991; 109: 244–251.
Leske MC, Wu SY, Hyman L, Sperduto R, Underwood B, Chylack LT et al. Biochemical factors in the lens opacities. Case–control study. The Lens Opacities Case–Control Study Group. Arch Ophthalmol 1995; 113: 1113–1119.
Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. The Italian–American Cataract Study Group. Am J Epidemiol 1991; 133: 541–553.
Mares-Perlman JA, Klein BE, Klein R, Ritter LL . Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology 1994; 101: 315–325.
Kuzniarz M, Mitchell P, Cumming RG, Flood VM . Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol 2001; 132: 19–26.
Cumming RG, Mitchell P, Smith W . Diet and cataract: the Blue Mountains Eye Study. Ophthalmology 2000; 107: 450–456.
McNeil JJ, Robman L, Tikellis G, Sinclair MI, McCarty CA, Taylor HR . Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology 2004; 111: 75–84.
Chylack Jr LT, Brown NP, Bron A, Hurst M, Kopcke W, Thien U et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002; 9: 49–80.
Mares-Perlman JA, Lyle BJ, Klein R, Fisher AI, Brady WE, VandenLangenberg GM et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol 2000; 118: 1556–1563.
Jacques PF, Chylack Jr LT, Hankinson SE, Khu PM, Rogers G, Friend J et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001; 119: 1009–1019.
Valero MP, Fletcher AE, De Stavola BL, Vioque J, Alepuz VC . Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr 2002; 132: 1299–1306.
Gale CR, Hall NF, Phillips DI, Martyn CN . Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology 2001; 108: 1992–1998.
Klein BE, Klein RE, Lee KE . Incident cataract after a five-year interval and lifestyle factors: the Beaver Dam eye study. Ophthalmic Epidemiol 1999; 6: 247–255.
Younan C, Mitchell P, Cumming RG, Panchapakesan J, Rochtchina E, Hales AM . Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Am J Epidemiol 2002; 155: 997–1006.
Klein BE, Klein R, Ritter LL . Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol 1994; 112: 85–91.
Klein BE, Klein R, Lee KE . Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the Beaver Dam Eye Study. Am J Ophthalmol 2000; 130: 322–326.
Freeman EE, Munoz B, Schein OD, West SK . Incidence and progression of lens opacities: effect of hormone replacement therapy and reproductive factors. Epidemiology 2004; 15: 451–457.
Weintraub JM, Taylor A, Jacques P, Willett WC, Rosner B, Colditz GA et al. Postmenopausal hormone use and lens opacities. Ophthalmic Epidemiol 2002; 9: 179–190.
Goodrich ME, Cumming RG, Mitchell P, Koutts J, Burnett L . Plasma fibrinogen and other cardiovascular disease risk factors and cataract. Ophthalmic Epidemiol 1999; 6: 279–290.
Klein BE, Klein R, Lee KE . Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: the Beaver Dam Eye Study. Am J Ophthalmol 1997; 123: 338–346.
Meyer D, Parkin D, Maritz FJ, Liebenberg PH . Abnormal serum lipoprotein levels as a risk factor for the development of human lenticular opacities. Cardiovasc J S Afr 2003; 14: 60–64.
McCarty CA, Nanjan MB, Taylor HR . Attributable risk estimates for cataract to prioritize medical and public health action. Invest Ophthalmol Vis Sci 2000; 41: 3720–3725.
Rowe NG, Mitchell PG, Cumming RG, Wans JJ . Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2000; 7: 103–114.
McCarty CA, Lee SE, Livingston PM, Bissinella M, Taylor HR . Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project model. Bull World Health Organ 1996; 74: 353–360.
Minassian DC, Mehra V, Jones BR . Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet 1984; 1: 751–753.
Harding JJ, Harding RS, Egerton M . Risk factors for cataract in Oxfordshire: diabetes, peripheral neuropathy, myopia, glaucoma and diarrhoea. Acta Ophthalmol (Copenh) 1989; 67: 510–517.
Bingham SA, Welch AA, McTaggart A, Mulligan AA, Runswick SA, Luben R et al. Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr 2001; 4: 847–858.
Acknowledgements
We are grateful to Tim Peters for initial advice on case–control selection and to Sue Williams and Clare Cross for administrative and clerical support.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
This work was funded by Regional R&D Project Grant, National Eye Research Centre.
Proprietary interests: None
Presented: RNIB Vision 2005, ARVO 2005
Rights and permissions
About this article
Cite this article
Durant, J., Frost, N., Trivella, M. et al. Risk factors for cataract subtypes waterclefts and retrodots: two case–control studies. Eye 20, 1254–1267 (2006). https://doi.org/10.1038/sj.eye.6702087
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.eye.6702087
Keywords
This article is cited by
-
Lens retrodots and vacuoles and their associations with the prevalence and incidence of age-related cataract
Eye (2012)
-
An increase in apoptosis and reduction in αB-crystallin expression levels in the lens underlie the cataractogenesis of Morioka cataract (MCT) mice
Medical Molecular Morphology (2011)